Emeis stock narrowly saves its 9.89 € support level, RSI in oversold territory at 20
After several weeks of decline, Emeis rebounds during the session and moves back above a technical threshold it had briefly broken through. The recovery occurs in a well-oriented Paris market, while the stock remains far from its moving averages.
A support briefly broken then reclaimed, RSI at 20
Emeis stock gains 2.07% to €10.09 in mid-afternoon trading, with the SBF 120 index rising 1.04%. During the session, the stock broke through its support at €9.89 down to a low of €9.88, before moving back above it. This failed downside attempt occurs as the RSI, at 20, reflects an oversold configuration following a decline of 21.42% over one month.
The recovery remains modest given the accumulated gap: the price is 10.94% below its 20-day moving average and more than 20% below its 50-day moving average, placing the stock far from any recovery zone. Over three months, the decline reaches 28.13%.
A half-year publication that raises the group's 2026 guidance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The first half 2026 results, published on July 29, led the group to raise its guidance for the year. It indicated at that time that the trend observed since the beginning of the fiscal year extended the momentum of 2025 and exceeded its initial expectations. The exit from Latin America, completed in early October for approximately €111 million in disposals, completes this refocusing.
The session is unfolding in a context of tension on French debt: the 10-year OAT is at 4.79% according to the latest Banque de France reading of October 9, or 1.32 points above the Bund. The latest reference technical level remains the support at €9.89, tested today.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 3 011 millions d'euros
Quarterly revenue: 3 011 millions d'euros
EBITDA: 461 millions d'euros
EBITDA margin: 15,3 %
Net income: -40,4 millions d'euros
Free cash flow: -153 millions d'euros
3 862 millions d'euros
Guidance from the release
First-half performance allows for an upward revision of the 2026 guidance; the trend since the start of the year confirms the continued momentum observed in 2025 and even shows performance that exceeded the Group's initial expectations
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.